View up-to-date information on Odonate Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
27 Aug 2020 | Odonate Therapeutics Prices Public Offering of Shares for USD80 Million | Equity Offering | - |
Odonate Therapeutics Inc |
25 Jun 2019 | Odonate Therapeutics to Raise USD100 Million in Public Offering of Shares | Equity Offering | - |
Odonate Therapeutics Inc |
05 Feb 2019 | Odonate Therapeutics Inc Enters Phase II Clinical Trial Agreement with Sarah Cannon Research Institute LLC for tesetaxel (GDCT0348851) | Contract Service Agreement |
Odonate Therapeutics Inc
Odonate Therapeutics Inc |
Sarah Cannon Research Institute LLC
Sarah Cannon Research Institute LLC
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer